FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
2.600
+0.190 (7.88%)
Nov 22, 2024, 4:00 PM EST - Market closed
FibroBiologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -17.78 | -16.49 | -5.12 | -1.58 | -1.17 |
| Depreciation & Amortization | 0.55 | 0.44 | 0.09 | - | - |
| Other Amortization | - | 0.08 | 0.39 | - | - |
| Stock-Based Compensation | 2.11 | 1.77 | 0.27 | - | - |
| Other Operating Activities | 3.54 | 7.31 | - | - | - |
| Change in Accounts Payable | 0.01 | 0.67 | 0.53 | 0.23 | - |
| Change in Other Net Operating Assets | 1.15 | -0.18 | -0.22 | -0.06 | - |
| Operating Cash Flow | -10.43 | -6.4 | -4.07 | -1.41 | -1.17 |
| Capital Expenditures | -0.09 | -0.5 | - | - | - |
| Investing Cash Flow | -0.09 | -0.5 | - | - | - |
| Short-Term Debt Issued | - | - | 4.3 | 2.28 | - |
| Total Debt Issued | 0.57 | - | 4.3 | 2.28 | - |
| Short-Term Debt Repaid | - | - | -0.23 | -0.75 | - |
| Total Debt Repaid | -0.46 | - | -0.23 | -0.75 | - |
| Net Debt Issued (Repaid) | 0.12 | - | 4.08 | 1.53 | - |
| Issuance of Common Stock | 7.46 | - | - | 0.29 | 1.17 |
| Other Financing Activities | - | -2.35 | -0.3 | - | - |
| Financing Cash Flow | 7.58 | 13.79 | 5.93 | 1.82 | 1.17 |
| Net Cash Flow | -2.94 | 6.9 | 1.86 | 0.41 | - |
| Free Cash Flow | -10.52 | -6.9 | -4.07 | -1.41 | -1.17 |
| Free Cash Flow Per Share | -0.33 | -0.24 | -0.14 | -0.16 | -0.13 |
| Cash Interest Paid | 0.02 | 0 | - | - | - |
| Levered Free Cash Flow | -0.47 | 3.97 | -1.69 | - | - |
| Unlevered Free Cash Flow | -0.46 | 3.98 | -1.67 | - | - |
| Change in Net Working Capital | -5.13 | -7.83 | -0.77 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.